Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations.
Canale M, Petracci E, Cravero P, Mariotti M, Minuti G, Metro G, Ludovini V, Baglivo S, Puccetti M, Dubini A, Martinelli G, Delmonte A, Crinò L, Ulivi P.
Canale M, et al. Among authors: baglivo s.
Transl Oncol. 2022 Sep;23:101471. doi: 10.1016/j.tranon.2022.101471. Epub 2022 Jun 29.
Transl Oncol. 2022.
PMID: 35779323
Free PMC article.